|Previous Section||Index||Home Page|
Table 3 sets out the recent data available on the mean BMI for adults in the East of England Government office region (GOR) from HSE 2003. Data on the mean BMI for children in the East of England is unavailable. Information on the mean BMI for adults and children in Suffolk, Bedfordshire, Cambridgeshire, Essex, Hertfordshire and Norfolk is also not available.
|Table 3: Mean body mass index for adults( 1) , by East England Government office region, 2003|
|(1 )Aged 16 and over. Source: Health Survey for England 2003. Department of Health.|
Ms Rosie Winterton: I am advised that the temporary suspension was due to system process errors that were brought to light during a routine audit being carried out by the Quality Assurance Service. The audit flagged up that women were not invited for further assessments, in line with service protocols, following their mammogram. All the women affected received a normal mammogram (i.e. no abnormalities appeared on the mammogram). However, the women had mentioned other possible symptoms during their appointment and guidelines specify that further assessment should take place.
I understand that Enfield Primary Care Trust is currently working towards the completion of detailed plans to reopen the service during April. The service has been subject to an external review by the National Breast Screening Service Quality Assurance Team. The implementation of all the recommendations arising from the review continues to form a key part of the planning process. The trust will be able to confirm the precise arrangements for resuming the service after the review team has completed its work, which is expected by the end of March.
The trust with their partner primary care trusts have an evolving action plan in place for the recommencement of screening and to clear the backlog, including investigating arrangements with other potential service providers and their ability to assist with the backlog.
The unit is currently developing a full plan to facilitate the recommencement of screening services. Once this is complete the trust will be able to advise on estimates. It will also depend on whether arrangements can be put into place to screen women at other sites across London and the surrounding area. Women who have been waiting longest will be seen on a priority basis.
Lynne Featherstone: To ask the Secretary of State for Health how many breast screening appointments were (a) made and (b) cancelled other than by the patient in each London primary care trust in each calendar year since 2000. 
Anne Milton: To ask the Secretary of State for Health how many women aged between 50 and 70 years are required to wait more than three years between breast cancer screenings in (a) Surrey Primary Care Trust and (b) England; what estimate her Department has made of the attendance take-up rate of women aged between 50 and 70 years attending breast cancer screenings in each area; and if she will make a statement. 
Ms Rosie Winterton: Surrey Primary Care Trust is covered by the breast screening unit based at the Jarvis Centre, Guildford. According to figures from January to March 2006, the average interval between screens for women at the Jarvis Centre was 33 months, and 92 per cent. of women were screened within 36 months of their previous screen. In England the average interval between screens for the same period was 36 months, with 68 per cent. of women being screened within 36 months of their previous screen.
We take the issue of the 36-month standard between screens very seriously. That is why Professor Mike Richards, the National Cancer Director, wrote to the chief executives of all 10 strategic health authorities in England on 9 February 2007 highlighting the importance of maintaining the 36-month interval.
Charlotte Atkins: To ask the Secretary of State for Health what assessment the Health Care Commission has made of (a) the quality of care delivered at Burton Independent Sector Treatment Centre and (b) the level of patient satisfaction with the delivery of care. 
As the independent inspection body for both the national health service and independent healthcare, the Healthcare Commission (HCC) is not part of the Department. Therefore, the information requested is not held centrally. However, information
on the reviews of services undertaken by the HCC are available on their website at: www.healthcare commission.org.uk
All Independent Sector providers, including the Midlands Treatment Centre located in Burton, are required to achieve HCC approval before services are commenced and to meet subsequent reviews. We can confirm that the Midlands Treatment Centre did receive HCC approval for the start of services in July 2006.
Charlotte Atkins: To ask the Secretary of State for Health (1) what the targeted case volume is for Burton Independent Sector Treatment Centre; and what proportion of that volume was achieved in each year since it was set up; 
Andy Burnham: The Midlands National Health Service Treatment Centre, situated in Burton, opened in July 2006. The case mix at the treatment centre continues to include ENT (ears nose and throat), general surgery, gynaecology, OMFS (face/jaw), ophthalmology, pain relief, plastics, rheumatology, trauma and orthopaedics and urology.
The Department measures independent sector treatment centre contract performance on the basis of value rather than activity. This is to allow for the variations, which can occur through substitution of activity between procedures of varying value.
Charlotte Atkins: To ask the Secretary of State for Health what impact the Burton Independent Sector Treatment Centre has had on (a) capacity and (b) waiting times in Staffordshire hospitals in each year since it was established. 
Andy Burnham: The Midlands Treatment Centre, located in Burton, has been able to provide additional surgical capacity in the Staffordshire area while offering patients a wider choice of provider for their treatment.
It is also believed that the facility has helped local national health service hospitals in achieving their maximum waiting time targets. As at January 2007, no patients in the Stoke on Trent, North Staffordshire and the South Staffordshire primary care trusts were waiting in excess of 26 weeks for inpatient treatment or 13 weeks for an outpatient appointment.
Andy Burnham: The Midlands National Health Service Treatment Centre, situated in Burton, provides training and supervision to its medical staff. The training includes continuing professional development, infection control, equipment and information management and technology.
Junior doctors work in the treatment centre alongside consultants as part of their training programme. The consultants remain responsible for clinical care and the training delivered as required. The agreement is that the direction and management of training of clinical trainees largely replicates current NHS training processes.
Caroline Flint: None. The Medical Research Council (MRC), one of the main agencies through which the Government supports medical and clinical research, is currently funding a broad portfolio of cancer research, including early stage trials and basic and underpinning research. The MRC has not received or considered any proposals to assess the effectiveness of dichloroacetate in attacking cancer cells. The Council always welcomes high quality applications for support in any aspect of biomedical research and these are judged in open competition with other demands on funding.
Mr. Laurence Robertson: To ask the Secretary of State for Health how many people diagnosed with cancer there were in (a) England and Wales and (b) Gloucestershire, broken down by type of cancer in each of the last five years for which figures are available. 
As National Statistician, I have been asked to reply to your recent Parliamentary Question asking how many people diagnosed with cancer there were in (a) England and Wales and (b) Gloucestershire, broken down by type of cancer in each of the last five years for which figures are available. 
The latest available figures for newly diagnosed cases (incidence) of cancer in England are for the years 2004. Figures for 2000-2004 for (a) England and Wales and (b) the county of Gloucestershire are given in Table 1 below. Table 1 provides data for all cancers excluding non-melanoma skin cancer and the four most common cancersbreast, colorectal, lung, and prostatewhich accounted for more than half of new cases of malignant cancer (excluding non-melanoma skin cancer) registered in England and Wales in 2004.
|Table 1: Registrations of newly-diagnosed cases of cancer: by selected cancer( 1) , sex and region, 2000-04|
|(1) Cancers are coded to the International Classification of Diseases (Tenth Revision):|
Colorectal C18-21, Lung C33-34, Breast C50, Prostate C61, All cancers excluding non-melanoma skin cancer C00-97 xC44.
Office for National Statistics
|Next Section||Index||Home Page|